Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pain × Cannabidiol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 4 Seizures 3 Colonic Neoplasms 3 Breast Neoplasms 3 Sturge-Weber Syndrome 2 Neoplasms 2 Nausea 2 Marijuana Abuse 2 Lennox Gastaut Syndrome 2 Glioblastoma 2 Epilepsies, Myoclonic 2 Anxiety Disorders 2 Vomiting 1 Solid Tumor 1 Rectal Neoplasms 1 Parasomnias 1 Pancreatic Neoplasms 1 Pain 1 Multiple Myeloma 1 Liver Neoplasms 1 Liver Cirrhosis 1 Gallbladder Neoplasms 1 Dysgeusia 1 Drug Resistant Epilepsy 1 Colorectal Neoplasms 1 Cognitive Dysfunction 1 Chemotherapy-Induced Peripheral Neuropathy 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Hepatocellular 1 Cancer Pain 1

Interventions

Fentanyl 24 Analgesia 21 Morphine 17 Acupuncture Therapy 17 Surveys and Questionnaires 15 Zoledronic Acid 13 Therapeutics 13 Oxycodone 13 Acetaminophen 13 Psychiatric Rehabilitation 12 Ketamine 12 Radiotherapy 11 Lidocaine 11 Hydromorphone 11 Methadone 10 Ibandronic Acid 10 nabiximols 9 Ropivacaine 9 Bupivacaine 9 Analgesics, Opioid 7 Early Intervention, Educational 6 Water 5 Tapentadol 5 Pregabalin 5 Music Therapy 5 Methods 5 Docetaxel 5 Cryotherapy 5 Cryosurgery 5 Control Groups 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03948074 2025-09-10

CAFCARS

British Columbia Cancer Agency

Phase 2 Completed

Anxiety Disorders, Nausea, Pain, Parasomnias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡